Star Lake Bioscience Co., Inc.Zhaoqing Guangdong

Shanghai Stock Exchange 600866.SS

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Total Non-Current Liabilities for the year ending December 31, 2023: USD 295.07 M

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Total Non-Current Liabilities is USD 295.07 M for the year ending December 31, 2023, a -2.89% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Total Non-Current Liabilities for the year ending December 31, 2022 was USD 303.87 M, a 638.56% change year over year.
  • Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Total Non-Current Liabilities for the year ending December 31, 2021 was USD 41.14 M, a 34.98% change year over year.
  • Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Total Non-Current Liabilities for the year ending December 31, 2020 was USD 30.48 M, a 139.15% change year over year.
  • Star Lake Bioscience Co., Inc.Zhaoqing Guangdong Total Non-Current Liabilities for the year ending December 31, 2019 was USD 12.75 M, a -33.54% change year over year.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
Loading...
SV Wall Street
Shanghai Stock Exchange: 600866.SS

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong

CEO Mr. Ying Jun EMBA
IPO Date Aug. 18, 1994
Location China
Headquarters No.67 Gongnong North Road
Employees 9,012
Sector Healthcare
Industries
Description

Star Lake Bioscience Co., Inc. manufactures and sells pharmaceutical raw materials, and food and feed additives in China and internationally. The company offers guanosine that is used as an intermediate for food and pharmaceutical raw material; L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; adefovir dipivoxil tablets used to reduce the activity of HBV DNA polymerase and anti-virus by destroying Hepatitis B virus DNA; and L-threonine that is used in premixtures, and pig and poultry feed. It also provides disodium 5'-ribonucleotide to cure chronic hepatitis, muscular atrophy, and eye diseases; disodium 5-inosinate to cure leukopenia, thrombocytopenia, and chronic and acute hepatitis; and inosine, which is used for the treatment of chronic hepatitis, heart disease, leukopenia or thrombocytopenia, central choroidoretinitis, etc. In addition, the company offers disodium 5'-guanylate for canned meat, ham, salted meat, etc. Further, it provides ribavirin, adenosine, adenine, memantine hydrochloride, arginine, D-ribose, fructose syrup, L-valine, L-threonine, L-lysine, etc. The company offers its products under the Star Lake and Yue Bao brands. Star Lake Bioscience Co., Inc. was founded in 1964 and is based in Zhaoqing, China.

Similar companies

600812.SS

North China Pharmaceutical Company Ltd.

USD 0.76

NA

600851.SS

Shanghai Haixin Group Co., Ltd.

USD 0.88

NA

600868.SS

Guangdong Meiyan Jixiang Hydropower Co.,Ltd.

USD 0.36

NA

600872.SS

Jonjee Hi-tech Industrial & Commercial Holding Co., Ltd.

USD 2.91

NA

600835.SS

Shanghai Mechanical & Electrical Industry Co.,Ltd.

USD 2.45

NA

StockViz Staff

February 2, 2025

Any question? Send us an email